OMPOSITIONioni.pom.go.id/sites/default/files/obat_baru/Cardura XL_Doksazosin... · been observed...
15
Genec Name: Doin Mesyl31e GITS Trademar CAL Product Dument No.: 191 Dnte: November 18, 2008 Suפrsed : NA PT PFIZER INDONESIA LOCAL PRODUCT DOC Generic Name : Doxazosin Mesy!ate GITS Trademark: CAA XL Product Document No.: 191 Date: November 18, 2008 Supersedes : NA N OF DIC PROD � CDAXL � QUALITATE AiD QUANTITATIVE OOSITION Active Ingredient: doxazosin ; � The GITS tablets contain doxazosin mesylate equivalent to 4 and 8 mg doxazosin. PHARMACEUTIC FORI Controlled release tablets CLC PARTICULARS Therapeutic indications Benign Prostatic Hyperplasia Doxazosin GITS is indicated r the treatment of clinical symptoms in benign prostatic hyperplasia (BPH) and r reduced urinary flow associated with BPH. Doxazosin may be used in BPH patients who are either hypertensive ofnormotensive. While the blood pressure changes in normotensive patients with BPH are clinically insignificant, patients with hypertension and BPH have had both conditions effectively treated with doxazosin monotherapy . Posolo and method of administration Doxazosin GITS can be taken with or without od. The GITS tablets should be swallowed whole with a sufficient amount of liquid. Patients should not chew, divide or crush the tablets (see section Special warnings and precautions r use: rmation/or Patients). 1
Transcript of OMPOSITIONioni.pom.go.id/sites/default/files/obat_baru/Cardura XL_Doksazosin... · been observed...
-
Generic Name: Doxazo.iin Mesyl31e GITS Trademark: CARDURAXL Product Document No.: 191 Dnte: November 18, 2008 Supersedes : NA
PT PFIZER INDONESIA
LOCAL PRODUCT DOCUMENT
Generic Name : Doxazosin Mesy!ate GITS Trademark: CARDURA XL Product Document No.: 191 Date: November 18, 2008
Supersedes : NA
NAME OF MEDICJNAL PROD�
CARDURAXL �
QUALITATIVE Ai'ID QUANTITATIVE
